Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua J Neumiller

Showing results (31-40 of 110) with videos related to

Pageof 11
Sort By:
Expert Opinion on Investigational Drugs|September 24, 2008
Janumet: a combination product suitable for use in patients with Type 2 diabetesJonathan Kent Reynolds, Joshua J Neumiller, R Keith Campbell
Current Opinion in Nephrology and Hypertension|May 17, 2023
Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney diseaseRadica Z Alicic, Joshua J Neumiller, Katherine R Tuttle
Clinical Therapeutics|March 15, 2005
Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organismsMark W Garrison, Joshua J Neumiller, Stephen M Setter
Advances in Chronic Kidney Disease|December 19, 2021
Overcoming Barriers to Implementing New Therapies for Diabetic Kidney Disease: Lessons LearnedJoshua J Neumiller, Radica Z Alicic, Katherine R Tuttle
Drugs|March 9, 2010
Sodium-glucose co-transport inhibitors: progress and therapeutic potential in type 2 diabetes mellitusJoshua J Neumiller, John R White, R Keith Campbell
Currents in Pharmacy Teaching & Learning|April 19, 2021
Teaching advanced pharmacy practice experience students to be effective teachers of second-year pharmacotherapy studentsAndrew A Yabusaki, Kimberly C McKeirnan, Joshua J Neumiller
Clinical Kidney Journal|January 12, 2024
Optimization of guideline-directed medical therapies in patients with diabetes and chronic kidney diseaseJoshua J Neumiller, Radica Z Alicic, Katherine R Tuttle
Seminars in Nephrology|October 19, 2023
Incorporating Evidence and Guidelines for Personalized Care of Diabetes and Chronic Kidney DiseaseJoshua J Neumiller, Radica Z Alicic, Katherine R Tuttle
Nature Reviews. Nephrology|January 8, 2026
GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney diseaseRadica Z Alicic, Joshua J Neumiller, Katherine R Tuttle
Journal of Clinical Medicine|April 9, 2024
Type 2 Diabetes and Chronic Kidney Disease: An Opportunity for Pharmacists to Improve OutcomesJoshua J Neumiller, Wendy L St Peter, Jay H Shubrook
Pageof 11

Showing results (31-40 of 110) with videos related to

Sort By:
Pageof 11
Expert Opinion on Investigational Drugs|September 24, 2008
Janumet: a combination product suitable for use in patients with Type 2 diabetesJonathan Kent Reynolds, Joshua J Neumiller, R Keith Campbell
Current Opinion in Nephrology and Hypertension|May 17, 2023
Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney diseaseRadica Z Alicic, Joshua J Neumiller, Katherine R Tuttle
Clinical Therapeutics|March 15, 2005
Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organismsMark W Garrison, Joshua J Neumiller, Stephen M Setter
Advances in Chronic Kidney Disease|December 19, 2021
Overcoming Barriers to Implementing New Therapies for Diabetic Kidney Disease: Lessons LearnedJoshua J Neumiller, Radica Z Alicic, Katherine R Tuttle
Drugs|March 9, 2010
Sodium-glucose co-transport inhibitors: progress and therapeutic potential in type 2 diabetes mellitusJoshua J Neumiller, John R White, R Keith Campbell
Currents in Pharmacy Teaching & Learning|April 19, 2021
Teaching advanced pharmacy practice experience students to be effective teachers of second-year pharmacotherapy studentsAndrew A Yabusaki, Kimberly C McKeirnan, Joshua J Neumiller
Clinical Kidney Journal|January 12, 2024
Optimization of guideline-directed medical therapies in patients with diabetes and chronic kidney diseaseJoshua J Neumiller, Radica Z Alicic, Katherine R Tuttle
Seminars in Nephrology|October 19, 2023
Incorporating Evidence and Guidelines for Personalized Care of Diabetes and Chronic Kidney DiseaseJoshua J Neumiller, Radica Z Alicic, Katherine R Tuttle
Nature Reviews. Nephrology|January 8, 2026
GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney diseaseRadica Z Alicic, Joshua J Neumiller, Katherine R Tuttle
Journal of Clinical Medicine|April 9, 2024
Type 2 Diabetes and Chronic Kidney Disease: An Opportunity for Pharmacists to Improve OutcomesJoshua J Neumiller, Wendy L St Peter, Jay H Shubrook
Pageof 11